DocGo (DCGO) Soars 7.9%: Is Further Upside Left in the Stock?

Company Overview - DocGo Inc. (DCGO) shares increased by 7.9% to $5.44 in the last trading session, with a notable trading volume, and have gained 23.5% over the past four weeks [1][2] Recent Developments - The recent price rise is attributed to investor optimism following DocGo's acquisition of PTI Health, which provides mobile lab collection and phlebotomy services, enhancing the company's ability to offer timely blood collection and at-home testing services [2] Financial Expectations - DocGo is projected to report quarterly earnings of $0.04 per share, reflecting a year-over-year decline of 33.3%. Expected revenues are $128.57 million, down 35.5% from the same quarter last year [3] - The consensus EPS estimate for DocGo has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - DocGo operates within the Zacks Medical Services industry, which includes other companies like Establishment Labs Holdings Inc. (ESTA). ESTA's stock closed 5.8% higher at $30.15, but has seen a return of -37.7% over the past month [4] - Establishment Labs' consensus EPS estimate for the upcoming report is -$0.62, representing a year-over-year change of +21.5%, and it currently holds a Zacks Rank of 4 (Sell) [5]